| HLA-DPB2 |
|
major histocompatibility complex, class II, DP beta 2 (pseudogene)
|
|
|
0.743 |
0.500 |
| IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| KIR2DL2 |
P43627
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
|
Receptor
|
|
0.612 |
0.654 |
| KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
| KIR2DS3 |
Q14952
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 3
|
Receptor
|
|
0.716 |
0.423 |
| MMP12 |
P39900
|
matrix metallopeptidase 12
|
Enzyme
|
|
0.484 |
0.885 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| H4C14 |
P62805
|
H4 clustered histone 14
|
|
|
0.541 |
0.692 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| SPZ1 |
Q9BXG8
|
spermatogenic leucine zipper 1
|
|
|
0.507 |
0.769 |
| DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| TPI1P2 |
|
triosephosphate isomerase 1 pseudogene 2
|
|
|
0.839 |
0.115 |
| LINC01193 |
|
long intergenic non-protein coding RNA 1193
|
|
|
0.565 |
0.692 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
| MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
| MIR145 |
|
microRNA 145
|
|
|
0.431 |
0.846 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR150 |
|
microRNA 150
|
|
|
0.455 |
0.808 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR17 |
|
microRNA 17
|
|
|
0.459 |
0.846 |